Oruka Therapeutics, Inc. is a biotechnology company, which focuses on developing novel monoclonal antibody therapeutics for PsO and other I&I indications. Its pipeline includes ORKA-001 and ORKA-002. The company is headquartered in Menlo Park, CA.
Name / Ticker | Price | Zen Rating |
---|---|---|
$2.89 | A | |
$42.51 | A | |
$8.11 | A |